Skip to main content

Verification & Compliance Record

Enforcement records
Full FDA/FTC/Health Canada enforcement-records search not yet performed for NextGenRx Compounding Pharmacy.
Website reachable
The listed website responded to the most recent check.

PeptideBase reports publicly documented information for educational purposes. This is not medical or legal advice, and listing does not constitute endorsement.

Are you NextGenRx Compounding Pharmacy? Claim this listing to update your information and add verification.

Claim listing
503A Pharmacy

NextGenRx Compounding Pharmacy

Broken Arrow, Oklahoma, United States

No rating available

NextGenRx is a compounding pharmacy located in south Broken Arrow, Oklahoma, offering customized testosterone formulations including compounded blends and testosterone cypionate. They serve the northeast Oklahoma region and provide various testosterone preparations with membership pricing options available. The pharmacy focuses on cost-effective medications and fills prescriptions from patients' healthcare providers.

Provider Details

503A Compounding Pharmacy

Prescriptions are required. Compounds are prepared to order for individual patients and cannot be sold in bulk without a physician order.

Coverage

Country
United States
State
Oklahoma
Telehealth
Not available
Regions Served
United States

Compliance

Compliance Type
503A Compounding

Verification & FDA Records

Data sources

  • Domain registrationRegistered Mar 2017
    Checked Jun 2026Source

Commercial relationships never influence ranking, verification status, or scoring.

0 paid placements in this directory.

Report an error

NextGenRx Compounding Pharmacy

Use this form to flag incorrect data, outdated information, or a misattributed finding. Our team reviews every report.

Related providers

Track this provider

Know when NextGenRx Compounding Pharmacy changes.

Get an email when their listing details, reviews, or peptide list are updated.

PeptideBase badge

Add this badge to your website

Profile last updated

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.